PepGen Inc
PEPG
NASDAQ
Biotechnology
$2.99
USD
+0.01 (+0.34%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $206.39M
Volume 612.4K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-71.94M
TTM
+25.8%
YoY
Operating Cash Flow
$-69.34M
TTM
+23.0%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 5.5 | 5.2 | 5.9 | 5.9 | 6.4 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 23.9 | 18.7 | 19.7 | 18.9 | 18.9 |
Operating Income | -23.9 | -18.7 | -19.7 | -18.9 | -18.9 |
EBITDA | -23.6 | -18.3 | -19.4 | -18.6 | -18.7 |
Other Income / Expense | 0.0 | -0.0 | -0.0 | -0.1 | 0.1 |
Total Other Income / Expense | 0.8 | 0.6 | 1.4 | 1.2 | 1.1 |
Income Before Income Taxes | -23.1 | -18.0 | -18.3 | -17.7 | -17.8 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -23.1 | -18.0 | -18.3 | -17.8 | -17.8 |
Consolidated Net Income / Loss | -23.1 | -18.0 | -18.3 | -17.8 | -17.8 |
Net Income Attributable to Common Shareholders | -23.1 | -18.0 | -18.3 | -17.8 | -17.8 |
Basic EPS | -$0.70 | -$0.52 | -$0.27 | -$0.26 | -$0.26 |
Diluted EPS | -$0.70 | -$0.52 | -$0.27 | -$0.26 | -$0.26 |
Basic Shares Outstanding | 32.7M | 34.4M | 69.1M | 69.1M | 69.2M |
Diluted Shares Outstanding | 32.7M | 34.4M | 69.1M | 69.1M | 69.2M |